When a sonographically visible lesion needs tissue diagnosis, ultrasound biopsy on breast tissue is usually the first-line image-guided method. Real-time guidance confirms that the needle traverses the target, positioning is comfortable, and ionizing radiation is not required. Used well, it is faster than stereotactic sampling for most masses and lets you adjust the path if the lesion shifts. This walkthrough is for clinicians who perform or assist with the procedure. It covers indications, approach, sampling, marker placement, concordance, and pitfalls, and it supports clinical judgment rather than serving as advice for any individual patient.
Indications for Ultrasound Biopsy on Breast
If the finding is clearly seen on ultrasound and tissue diagnosis is indicated, ultrasound is generally preferred. Typical targets are solid masses, complex cystic lesions, intraductal masses, sonographically visible architectural distortion, and suspicious intramammary or axillary nodes. Correlate palpable findings with a sonographic target before you sample so you are biopsying the lesion that prompted the request.
Most procedures are done for BI-RADS Category 4 or BI-RADS 5 assessments. Subcategories frame the pretest likelihood of malignancy and the counseling conversation, but they do not replace histology. BI-RADS 3 lesions are usually followed. Biopsy of a probably benign finding may still be reasonable when follow-up is unreliable or after informed preference. Assign the assessment using the full BI-RADS categories on breast ultrasound before you commit to sampling.
When ultrasound is the preferred guidance method
- The target is well seen and a path parallel to the chest wall is safe.
- A mammographic or MRI finding has a confident sonographic correlate, documented before sampling.
- Avoiding radiation is desirable, including in pregnancy, and a sonographic target exists.
- An axillary or intramammary node requires sampling for diagnosis or staging.
When another method is usually better
Calcifications without a mass, distortion without a sonographic correlate, and some asymmetries belong on stereotactic or tomosynthesis guidance. MRI-only lesions without a correlate belong on MRI-guided biopsy. Do not biopsy a nearby cyst or unrelated hypoechoic area as a substitute for the true target. Re-review the original mammogram or MRI if the ultrasound match is uncertain.
Preprocedure Planning and Approach Selection
Review the study that prompted biopsy. Confirm laterality, clock-face position, distance from the nipple, depth, and relationship to skin, chest wall, implant, and nipple-areolar complex. Scan the finding yourself. Mark the skin only after you have a stable window and a safe throw.
Counsel on why tissue is needed, what sampling feels like, marker placement, and how results will be communicated. Review allergies, implants, prior surgery, and bleeding risk using your facility policy and current society guidance. Many spring-loaded core biopsies proceed with local hemostasis. Vacuum-assisted sampling and higher bleeding risk may need extra coordination with the referring clinician.
Positioning and needle path
Thin the breast and stabilize the lesion. Supine or posterior oblique with the ipsilateral arm raised is typical for outer lesions. Inner lesions often need a steeper oblique. Use a high-frequency linear transducer. Set depth, focal zone, and gain so the needle and target stay visible along the entire path.
Choose a path that stays parallel to the chest wall, especially in thin patients and the axillary tail, avoids the nipple-areolar complex when another window exists, runs parallel to an implant surface, leaves enough subcutaneous run for the throw, and keeps the needle in-plane with the lesion for the entire pass.
Trajectory pearls
In-plane guidance is standard because you see shaft and tip continuously. Out-of-plane imaging makes the tip easy to lose. Measure skin-to-lesion and skin-to-chest-wall distances. For spring-loaded devices, include the throw beyond the tip. For vacuum-assisted devices, know where the aperture sits relative to the cutter so you center the trough in the lesion, not in front of it or past it.
Sampling Technique, Devices, and Marker Placement
An ultrasound biopsy for breast lesions is typically a percutaneous core. Fine-needle aspiration still has a role for some nodes and cystic lesions when cytology is sufficient, but core histology is the usual standard for solid masses.
Local anesthesia and entry
Use your sterile skin prep and drape. Raise a wheal, then infiltrate the track to the lesion and around it, including the far side when safe. Allow time to work. A small dermatotomy eases larger cores and vacuum probes. Re-image after infiltration. Anesthetic can obscure or displace a subtle target, so confirm the lesion before you sample.
Device selection
- Spring-loaded core needles suit most masses that can be targeted with a 14-gauge or similar device. Obtain several intact cores. Take more if fragments are poor or the lesion is heterogeneous.
- Vacuum-assisted devices yield larger volume, which helps with small masses, complex cystic lesions, and some distortion, and they can reduce the problem of a mobile lesion that rolls away from a spring throw.
- Fine-needle aspiration may be used for selected nodes or cyst fluid, with the limits of cytology in mind.
Stay with generic device classes. Match needle throw and specimen handling to your inventory and pathologist.
Confirming the needle in the target
Document alignment before you fire or activate the cutter. After the pass, document the needle or trough through the lesion in two orthogonal planes when you can. One plane can look central while the shaft is tangent to the mass. Small lesions should move with the needle or show the trough opening inside them. If hematoma erases the target after the first pass, finish representative sampling quickly and place the marker while the cavity is still visible.
Clip placement
Place a tissue marker when the lesion is small, when hematoma may hide it, when neoadjuvant therapy is possible, or when later localization is likely. Many practices mark malignant, high-risk, and even concordant benign sites so the cavity can be found later. Deploy under ultrasound and confirm the clip in the cavity. A two-view mammogram documents position relative to the original mammographic landmark and catches immediate migration into hematoma or along the track. If the clip has migrated, say so in the report so future localization uses residual lesion or hematoma, not the marker alone.
Axillary and intramammary nodes
Target thickened cortex, not the echogenic hilum. Core tissue supports histology and receptor testing when metastatic disease is present. Fine-needle aspiration may fit some staging algorithms. Avoid the hilar vessel. Record axillary level or intramammary location and nearby vessels so a positive result is surgically useful.
Ultrasound-Guided versus Stereotactic Breast Biopsy
Use the modality that shows the target most clearly and safely. Ultrasound is usually faster for masses, gives real-time needle control, and avoids compression and radiation. Stereotactic or tomosynthesis guidance remains the better choice for calcifications and for mammographic findings without a sonographic correlate. Structured review of stereotactic breast biopsy is useful if you also cover that service. Do not recast a calcification-only finding as an ultrasound biopsy of a nearby unrelated structure.
Common Pitfalls and How to Avoid Them
- Wrong target. Match size, shape, distance from the nipple, and surrounding landmarks to the original study before you anesthetize. Nearby fibroadenomas, fat lobules, and costal cartilage are classic decoys.
- Single-plane confirmation. Turn the probe. A needle that looks central in one plane may skim the edge in the other.
- Inadequate tissue. Inspect cores as you obtain them. Fatty, fragmented, or off-target samples should trigger more passes or a device change, not a benign report you cannot trust.
- Chest wall or implant injury. Keep the path parallel to the chest wall. For implants, keep the surface in view for the entire pass.
- Superficial and nipple-adjacent lesions. Use a shallow approach and a shorter throw so you do not submit a skin-only core or injure the nipple-areolar complex.
- Lesion displacement. Mobile masses can roll off a spring-loaded throw. Stabilize with the transducer, enlarge the dermatotomy, or switch to a vacuum-assisted device.
- Hematoma and clip migration. Hold pressure over the lesion and the track. Place the marker while the cavity is visible. Report displacement so localization is not planned to a migrated clip.
- Radiology-pathology discordance. A benign result for a BI-RADS 5 mass, missing calcifications when those were the target, or unexpected histology should lead to repeat biopsy or excision, not routine follow-up.
Hemostasis, Aftercare, and Concordance
Hold firm pressure over the track and the lesion, not only the skin nick. A simple closure and dressing are typical. Counsel on ice, limited activity for the rest of the day, and warning signs of expanding hematoma or infection. Bruising is expected. Most patients return to usual activity the next day.
Correlate pathology with imaging in an addendum. Concordant benign results follow your multidisciplinary pathway and the original BI-RADS assessment. High-risk histologies (atypical hyperplasia, lobular neoplasia, some papillary lesions, radial scar, and similar findings) generally need surgical or tumor-board review because of upgrade risk. The exact pathway depends on histology, sample adequacy, and local practice. Malignant results go to the treatment team. State whether the result is concordant and what imaging or clinical step comes next.
Room time for a straightforward single target is commonly well under an hour, including consent, sampling, marker films, and a short observation period. Multiple sites, small or deep lesions, and extra hemostasis take longer. Needle sampling itself is brief.
Used with a correct target, a safe path, two-plane documentation, a marker when the site may be hard to find later, and honest radiology-pathology concordance, ultrasound-guided sampling is an efficient way to complete the diagnostic workup. IAME offers accredited ultrasound CME courses on this topic, including an ultrasound-guided breast biopsy course for clinicians who want additional technique review.
Frequently Asked Questions
How painful is an ultrasound breast biopsy?
With local anesthetic along the path and around the lesion, most patients describe pressure and brief discomfort rather than sharp pain. Vacuum-assisted sampling and work near the nipple can feel more intense. Let the anesthetic work, and add more if the patient reports pain rather than pressure. Soreness and bruising for a few days are common.
Can a radiologist tell if it is breast cancer on ultrasound?
Classic malignant features can make ultrasound highly suggestive, which is why BI-RADS 5 exists, but imaging is not a histologic diagnosis. Overlap is common, especially among BI-RADS 4 lesions. Use ultrasound to find, characterize, and sample. Do not treat a sonographic appearance as a substitute for tissue.
Should I be worried if I have to have a breast biopsy?
A biopsy means the finding needs a tissue diagnosis, not that cancer has been established. Many image-guided biopsies are benign. After the procedure, concordance and a defined next step matter more than the fact that sampling was recommended. When you counsel, explain the assessment, the procedure, and how results will be delivered.
What percentage of breast biopsies turn out to be cancerous?
No single percentage applies across practices. Yield tracks the BI-RADS assessment, the mix of screening and diagnostic patients, and which lesions are biopsied rather than followed. BI-RADS 4A findings are malignant far less often than BI-RADS 5 masses. When patients ask, quote the assessment-specific range used in the report rather than a global positivity rate.
How long does an ultrasound-guided breast biopsy take?
Once the lesion is in a stable window, needle sampling usually takes only a few minutes. Total appointment time for a single straightforward target is commonly well under an hour. Plan more time for multiple sites, small or deep lesions, and patients who need extra positioning or hemostasis.
